CJC-1295 with DAC is a synthetic research peptide modeled after growth hormone-releasing hormone (GHRH), the natural hormone responsible for signaling the pituitary gland to release growth hormone. The Drug Affinity Complex (DAC) modification was designed to extend the peptide’s activity in experimental settings.
Research has explored CJC-1295 with DAC in connection with growth hormone signaling, IGF-1 activity, pituitary function, and endocrine regulation. Scientists study these pathways to better understand the relationship between GHRH signaling, growth factors, metabolism, and other physiological processes.
Ophir Health CJC-1295 with DAC provides a precisely measured format for laboratory research involving GHRH pathways, growth hormone signaling, IGF-1 activity, and endocrine research.
